Prof. Özlem Er is a medical oncologist with a strong academic and clinical background. She earned her professorship from Acibadem University Faculty of Medicine in 2010 and has been affiliated with Acibadem Health Group since 2018. Her work focuses on advancing cancer care through clinical practice, research, and collaboration. Active in the oncology community, Prof. Er holds memberships in leading professional organizations, including ASCO (American Society of Clinical Oncology), ESMO (European Society for Medical Oncology), the Turkish Oncology Group, the Medical Oncology Society, and the Turkish Cancer Research and Control Society. These affiliations reflect her commitment to staying current with oncology advances and contributing to multidisciplinary efforts in cancer treatment and control.
Education
- 2010 Acibadem University Faculty of Medicine / Professor
- 2003 Erciyes University Faculty of Medicine / Associate Professor
- 2002 Erciyes University Faculty of Medicine Medical Oncology
- 1999 Ankara Numune Training and Research Hospital Internal Medicine
- 1994 Hacettepe University Faculty of Medicine
Experience
- 2018 Acibadem Health Group
- 2002 – 2009 Erciyes University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Faculty Member
- 2006 – 2008 Thomas Jefferson University Breast Cancer Research (Research Fellow)
- 2005 – 2007 Head of Department of Medical Oncology, Erciyes University Faculty of Medicine
- 2003 – 2004 MD Anderson Cancer Center Breast Cancer Clinical Research (Clinical Observer)
- 1999 – 2002 Erciyes University Faculty of Medicine Medical Oncology Residency
- 1994 – 1999 Ankara Numune Training and Research Hospital Internal Medicine Residency
Memberships
- ASCO (American Society Of Clinical Oncology)
- ESMO (European Society or Medical Oncology)
- Turkish Oncology Group
- Medical Oncology Society
- Turkish Cancer Research and Control Society
Publications
- Cyclooxygenase-2 expression in gastrointestinal stromal tumors.
Asian Pac J Cancer Prev. 2010;11(4):849-53 Sevinc A, Camci C, Sari I, Kalender ME, Er O, Soyuer I, Dikilitas M, Yilmaz U, Sagol O, Alacacioglu A. - Intramuscular metastases detected by PET/CT in a patient with renal cell tumor.
V Beylergil, O. Er, Z. Calıkuşu, E. Vardareli. Acibadem University Journal of Health Sciences 2010: 1: 49-50 - Capecitabine:Use except in breast and colorectal cancers.
Remission Journal of Current Oncology 2010: 10 (1): 27-39 Ozlem Er, Halit Karaca. - ERCC1 is not expressed in hepatocellular cancer: A Turkish Oncology Group.
Journal of BUON 2010;15:794-796 N. Serdar Turhal, E. Bas, O. Er, M. Aliustaoglu, S. Seber, F. Dane, T. Korkmaz, I. Soyuer, S. Ozkara, C. Celikel. - Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer.
Asian Pac J Cancer Prev. 2010;11(1):181-5 Ozkan M, Akbudak IH, Deniz K, Dikilitas M, Dogu GG, Berk V, Karaca H, Er O, Altinbas M. - Clinical Course Of Breast Cancer Patients With Metastases Limited To The Liver Treated With Chemotherapy.
Er O, Frye Dk, Kau Sw, Broglio K, Valero V, Hortobagyi Gn, Arun B.Cancer J. 2008 - Protective Effects Of Carvedilol Against Anthracycline-Induced Cardiomyopathy.
Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A, Inanc T, Oguzhan A, Eryol Nk, Topsakal R, Ergin A. J Am Coll Cardiol. 2006 - Management of Cancer-Associated Venous Thrombosis.
Er O, Zacharski L. Vasc Health Risk Manag. 2006 - Irinotecan Plus Cisplatin Combination Against Metastatic Gastric Cancer: Phase Ii Study.
Altinbas M, Er O, Ozkan M, Solak Y, Coskun Hs, Kucuk C, Gursoy S. Med Oncol. 2005 - A Randomized Clinical Trial Of Combination Chemotherapy With And Without Low-Molecular-Weight Heparin In Small Cell Lung Cancer.
Altinbas M, Coskun Hs, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S. J Thromb Haemost. 2004
